JankovicV1, PubMed, Corpus, bibRecord, 000043

Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.

Identifieur interne : 000043 ( PubMed/Corpus ); précédent : 000042; suivant : 000044

Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.

Auteurs : José Baizabal ; Joseph Jankovic

Source :

Neuromodulation : journal of the International Neuromodulation Society ; 2014.

RBID : pubmed:23663196

English descriptors

KwdEn :
- Adult, Antiparkinson Agents (therapeutic use), Cholinergic Antagonists (therapeutic use), Combined Modality Therapy, Deep Brain Stimulation, Disease Progression, Dopamine Agonists (therapeutic use), Drug Resistance, Drug Therapy, Combination, Humans, Levodopa (therapeutic use), Magnetic Resonance Imaging, Male, Neuronal Plasticity, Pallidotomy, Parkinson Disease, Secondary (drug therapy), Parkinson Disease, Secondary (surgery), Parkinson Disease, Secondary (therapy), Severity of Illness Index, Shoulder Joint (injuries), Subthalamic Nucleus (physiopathology).
MESH :
- chemical , therapeutic use : Antiparkinson Agents, Cholinergic Antagonists, Dopamine Agonists, Levodopa.
- drug therapy : Parkinson Disease, Secondary.
- injuries : Shoulder Joint.
- physiopathology : Subthalamic Nucleus.
- surgery : Parkinson Disease, Secondary.
- therapy : Parkinson Disease, Secondary.
- Adult, Combined Modality Therapy, Deep Brain Stimulation, Disease Progression, Drug Resistance, Drug Therapy, Combination, Humans, Magnetic Resonance Imaging, Male, Neuronal Plasticity, Pallidotomy, Severity of Illness Index.

DOI: 10.1111/ner.12071
PubMed: 23663196

Links to Exploration step

pubmed:23663196

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.</title>
<author><name sortKey="Baizabal Carvallo, Jose Fidel" sort="Baizabal Carvallo, Jose Fidel" uniqKey="Baizabal Carvallo J" first="José" last="Baizabal">José Baizabal</name>
<affiliation><nlm:affiliation>Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:23663196</idno>
<idno type="pmid">23663196</idno>
<idno type="doi">10.1111/ner.12071</idno>
<idno type="wicri:Area/PubMed/Corpus">000043</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.</title>
<author><name sortKey="Baizabal Carvallo, Jose Fidel" sort="Baizabal Carvallo, Jose Fidel" uniqKey="Baizabal Carvallo J" first="José" last="Baizabal">José Baizabal</name>
<affiliation><nlm:affiliation>Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
</author>
</analytic>
<series><title level="j">Neuromodulation : journal of the International Neuromodulation Society</title>
<idno type="e-ISSN">1525-1403</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Cholinergic Antagonists (therapeutic use)</term>
<term>Combined Modality Therapy</term>
<term>Deep Brain Stimulation</term>
<term>Disease Progression</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Drug Resistance</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Neuronal Plasticity</term>
<term>Pallidotomy</term>
<term>Parkinson Disease, Secondary (drug therapy)</term>
<term>Parkinson Disease, Secondary (surgery)</term>
<term>Parkinson Disease, Secondary (therapy)</term>
<term>Severity of Illness Index</term>
<term>Shoulder Joint (injuries)</term>
<term>Subthalamic Nucleus (physiopathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Cholinergic Antagonists</term>
<term>Dopamine Agonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="injuries" xml:lang="en"><term>Shoulder Joint</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Subthalamic Nucleus</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Combined Modality Therapy</term>
<term>Deep Brain Stimulation</term>
<term>Disease Progression</term>
<term>Drug Resistance</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Neuronal Plasticity</term>
<term>Pallidotomy</term>
<term>Severity of Illness Index</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">23663196</PMID>
<DateCreated><Year>2014</Year>
<Month>03</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1403</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>17</Volume>
<Issue>1</Issue>
<PubDate><Year>2014</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Neuromodulation : journal of the International Neuromodulation Society</Title>
<ISOAbbreviation>Neuromodulation</ISOAbbreviation>
</Journal>
<ArticleTitle>Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.</ArticleTitle>
<Pagination><MedlinePgn>104-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/ner.12071</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baizabal-Carvallo</LastName>
<ForeName>José Fidel</ForeName>
<Initials>JF</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jankovic</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>05</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Neuromodulation</MedlineTA>
<NlmUniqueID>9804159</NlmUniqueID>
<ISSNLinking>1094-7159</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018680">Cholinergic Antagonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018680">Cholinergic Antagonists</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003131">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D046690">Deep Brain Stimulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018491">Dopamine Agonists</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004351">Drug Resistance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009473">Neuronal Plasticity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D053860">Pallidotomy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010302">Parkinson Disease, Secondary</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012785">Shoulder Joint</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D020531">Subthalamic Nucleus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Deep brain stimulation</Keyword>
<Keyword MajorTopicYN="N">Parkinson's disease</Keyword>
<Keyword MajorTopicYN="N">peripherally induced parkinsonism</Keyword>
<Keyword MajorTopicYN="N">posttraumatic parkinsonism</Keyword>
<Keyword MajorTopicYN="N">subthalamic nucleus</Keyword>
<Keyword MajorTopicYN="N">surgical treatment</Keyword>
<Keyword MajorTopicYN="N">tremor</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year>
<Month>8</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2013</Year>
<Month>2</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>3</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2013</Year>
<Month>5</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>5</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>5</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">23663196</ArticleId>
<ArticleId IdType="doi">10.1111/ner.12071</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000043 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000043 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    JankovicV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:23663196
   |texte=   Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:23663196" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a JankovicV1

This area was generated with Dilib version V0.6.19.
Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024

	Serveur d'exploration autour de Joseph Jankovic
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration autour de Joseph Jankovic

Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.

Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki